A total of 22 relapsed or refractory ovarian cancer patients were treated with ifosfamide-containing polychemotherapy. Kinetic analyses were done to evaluate the tumor-cell-recruiting potential of the alkylating agent. Our study shows that ifosfamide can enhance tumor proliferative activity in pretreated ovarian cancers.
|Journal||Cancer Chemotherapy and Pharmacology|
|Issue number||1 Supplement|
|Publication status||Published - Jan 1990|
ASJC Scopus subject areas
- Cancer Research